Intrexon Corporation Raises $150 Million for Synthetic Biology Initiatives

News   May 02, 2013

 
Intrexon Corporation Raises $150 Million for Synthetic Biology Initiatives
 
 
 

RELATED ARTICLES

Scientists Develop a Synthetic Solution to Combat Dwindling Supply of Cancer and HIV Drug

News

Supplies of a promising drug for cancer, HIV and possibly other diseases is dwindling, and scientists have struggled to extract more from the marine creatures who produce it. Now, chemists have a synthetic solution.

READ MORE

Genomics Researchers Showcase their Applications of Droplet Digital PCR at ASHG 2017 Annual Meeting

News

The sensitivity and reliability of Droplet Digital PCR will be showcased in over a dozen presentations at the American Society of Human Genetics (ASHG) 2017 Annual Meeting.

READ MORE

Ingenza Advances inABLE® Biomanufacturing Technologies in Collaboration with Syngenta

News

Ingenza has reached a major technical milestone with Syngenta in their collaboration to develop efficient manufacturing technologies for innovative crop protection products.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE